Breaking News

Before his death, he warned of pandemic's toll on nurses; Moderna to ask FDA to authorize Covid vaccine in young kids

 

Daily Recap

'I fear the long-term effects': Before his death, a nurse warned of the pandemic's toll on health care workers

By Andrew Joseph

Photo illustration from handout

Critical care nurses say it isn't just the magnitude of death that has worn them down the past two years, but what those deaths became.

Read More

Moderna to ask FDA to authorize Covid-19 vaccine in children 6 months to 6 years

By Helen Branswell and Matthew Herper

Sergio Flores/Getty Images

The company's announcement comes as it released interim data from two clinical trials of its vaccine in children under 6 years of age.

Read More

STAT+: Scientists test tetanus bacteria as a weapon to target pancreatic tumors

By Angus Chen

Courtesy Claudia Gravekamp

Pancreatic cancer has proved one of the most deadly forms of the disease, and the most difficult to crack.

Read More

Opinion: Google's ongoing stem cell problem points to a larger issue with its search results on unproven therapies

By Paul Knoepfler

Adobe

Google's 2019 ban on stem cell clinics advertising unproven therapies didn't last long. Companies are gaming Google with SEO.

Read More

New Covid trial results may point toward better ways to study medicines

By Matthew Herper

NIH/Paola Perez, Ph.D.

A clinical trial called TOGETHER underlines the value of platform studies, streamlined studies that evaluated multiple medicines at once.

Read More

Opinion: Listen: Pharma companies market their drugs to young adults — so why don't they include them in clinical trials?

By Patrick Skerrett

This week on "The First Opinion Podcast," an activist talks about the need to include adolescents and young adults in clinical trials.

Read More

Wednesday, March 23, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments